Navigation Links
TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
Date:5/12/2008

4 20 8047 5543

Gary Davies +44 20 8047 5503

US Analyst/ Investor enquiries: Frank Murdolo +1 215 751 7002

Tom Curry +1 215 751 5419

REFERENCES

(1) Baselga J, et al. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer. The Oncologist. 2006;11 Suppl 1:4-12.

(2) Parkin DM, et al. Global cancer statistics, 2002. C A Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

(3) C. Bernard-Marty et al. Facts and Controversies in Treatment of Systemic Metastatic Breast Cancer. The Oncologist. 2004:9:617-632.

(4) TYKERB Prescribing Information, 2007.


'/>"/>
SOURCE GlaxoSmithKline; Breast International Group; SpanishBreast Cancer
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
2. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
3. Hospital Launches Landmark Emergency Medicine Project
4. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
5. Viatronix V3D-Colon Utilized in Another Landmark Study
6. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
7. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
8. Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema
9. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
10. Gene Therapy Provides Vision to People who Were Nearly Blind
11. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4TechNet Urges Swift U S Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell 12629 1TechNet Urges Swift U S Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell 12629 2TechNet Urges Swift U S Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell 12629 3IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 1IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 2IUPUI chemists develop Distributed Drug Discovery 3A Finding drugs for neglected diseases 48927 3Having a higher purpose in life reduces risk of death among older adults 48925 1Having a higher purpose in life reduces risk of death among older adults 48925 2Having a higher purpose in life reduces risk of death among older adults 48925 3